Ovarian Cancer Patients

You may help the family members who don’t yet have cancer by testing the ovarian cancer patients that do.

Ovarian Cancer Patients at Risk for BRCA Mutations are Under-Identified

  • A recent study shows physicians fail to identify more than 50% of ovarian cancer patients at substantial risk for BRCA1/2 mutations.

Why Should You Recommend BRACAnalysis Testing to Your Ovarian Cancer Patients?

  • NCCN Clinical Practice Guidelines Support BRACAnalysis Testing.
  • Physician guidelines6 recommend that any person with a personal or family history of ovarian cancer be tested for BRCA gene mutations.
  • One study reported that nearly 90% of ovarian cancer patients would want to have BRCA gene testing to let their family members know if there is an inherited gene mutation responsible for their cancer.

1 in 7 OVARIAN CANCERS1 ARE DUE TO BRCA MUTATIONS3,4,8
1_in_7_ovarian_cancers

BRCA Testing at the Time of Diagnosis Will:

  • Provide patients valuable information for their families
  • Reduce costs for family members
  • Provide valuable clinical insight into future cancer risk
  • Potentially identify patients for investigational treatment protocols (eg, PARP inhibitor therapy)

Hereditary Breast and Ovarian Cancer (HBOC) Syndrome Coverage and Testing Criteria:

  • Personal or family history of ovarian cancer* at any age
  • No further family history required

Time is Critical!
Genetic testing for women with ovarian cancer is especially important because of the significance of the results for the patient and family. Unfortunately, the window of opportunity for offering genetic testing is limited in many cases

ovarian

* Epithelial ovarian/fallopian tube/primary peritoneal cancer